Your shopping cart

Research Details

Should Pharmaceutical Scientists Use Liposomes or Micelles as A Means of Drug Delivery?

Should Pharmaceutical Scientists Use Liposomes or Micelles as A Means of Drug Delivery?

Research Project by Gifted Gabber Alumni - Mohammed Khan

Project's Result

Published in the Journal of Student Research: Access the Full Paper Here

 

Gifted Gabber Research Program

This impactful research was conducted during the 2022 Research Program at Gifted Gabber, under the guidance of Mentor Coach Jo.

 

Research Summary

Mohammed Khan’s research explores a critical question in pharmaceutical science: the efficacy of liposomes versus micelles as drug delivery systems. This study delves into the structural and functional advantages of both nanocarriers, evaluating their potential to revolutionize targeted drug delivery and improve therapeutic outcomes.

Liposomes, known for their biocompatibility and ability to encapsulate both hydrophilic and hydrophobic drugs, are compared with micelles, which excel in solubilizing poorly water-soluble drugs. The research highlights key parameters such as stability, drug release profiles, and their effectiveness in overcoming biological barriers.

Through a systematic review and analysis, Mohammed’s study provides insights into the applications of these carriers in treating diseases like cancer and chronic conditions. The findings underscore the significance of selecting the appropriate nanocarrier based on the therapeutic context, drug properties, and patient needs.

This groundbreaking work not only advances understanding in the field of nanomedicine but also offers practical recommendations for pharmaceutical scientists aiming to optimize drug delivery systems. Mohammed Khan’s research showcases the transformative potential of nanotechnology in enhancing patient care and addressing complex medical challenges.